1-8 of 8
vismodegib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)

Ridhi Gupta, MD, Abdulwahab Albabtain, MD, Sally Arai, MD, Bernice Kwong, MD, Wen-Kai Weng, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3409.
https://doi.org/10.1182/blood-2018-99-113915
Published: 2018
Journal Articles

"Direct to Drug" Screening As a Route to Individualized Therapy in Multiple Myeloma

Nathalie Meurice, PhD, Joachim L Petit, PhD, Cecilia Bonolo De Campos, PhD, Alysia N Polito, BS, Ilsel D Lopez Armenta, BS, Gregory J Ahmann, BS, Laura Ann Bruins, BS, Joseph R Mikhael, MD FRCPC, MD, Craig B. Reeder, MD, Angela A Mayo, MS, PA-C, P. Leif Bergsagel, MD, Rafael Fonseca, MD, Nikolai Sepetov, PhD, Sergei Romanov, PhD, A. Keith Stewart, MBChB, MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 3080.
https://doi.org/10.1182/blood.V130.Suppl_1.3080.3080
Published: 2017
Journal Articles

Phase 1b Results of a Study to Assess the Efficacy and Safety of Vismodegib in Combination with Ruxolitinib in Patients with Intermediate- or High-Risk Myelofibrosis

Stephen Couban, MDBSc, Giulia Benevolo, William Donnellan, Jennifer Cultrera, Steffen Koschmieder, Srdan Verstovsek, MD PhD, Gregory Hooper, Christian Hertig, Maneesh Tandon, Natalie Dimier, Ian Templeton, Francesco Passamonti
Journal: Blood
Blood (2017) 130 (Supplement 1): 4179.
https://doi.org/10.1182/blood.V130.Suppl_1.4179.4179
Published: 2017
Journal Articles

Inhibition of Hedgehog Signaling for the Treatment of Lymphoma and CLL: A Phase II Study from the Lysa

Roch Houot, MD PhD, Carole Soussain, MD, Hervé Tilly, MD PhD, Corinne Haioun, MD PhD, Catherine Thieblemont, Olivier Casasnovas, MD, Krimo Bouabdallah, MD, Franck Morschhauser, MD, Steven Le Gouill, MD PhD, Gilles A. Salles, MD PhD, Tony Marchand, MD, Céline Pangault, PharmD PhD, Camille Laurent, Thierry Lamy, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3970.
https://doi.org/10.1182/blood.V126.23.3970.3970
Published: 2015
Journal Articles

The Hedgehog Pathway As Targetable Vulnerability with 5-Azacitidine in MDS and AML

Raoul Tibes, MD PhD, Devora Delman, B.S., Nanna Hansen, M.S., Krisstina L. Gowin, DO, Ruben Mesa, MD, James M Bogenberger, PhD
Journal: Blood
Blood (2014) 124 (21): 4612.
https://doi.org/10.1182/blood.V124.21.4612.4612
Published: 2014
Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD
Journal: Blood
Blood (2013) 122 (21): 821.
https://doi.org/10.1182/blood.V122.21.821.821
Published: 2013
Journal Articles

Targeting the Hedgehog Signaling Pathway Limits the Self-Renewal of BCR-ABL1 Positive Leukemia Cells: Molecular Mechanisms

Tetsuzo Tauchi, M.D., Seiichiro Katagiri, M.D., Seiichi Okabe, M.D., Yosuke Minami, MD, PhD, Tomoki Naoe, MD, PhD, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 531.
https://doi.org/10.1182/blood.V120.21.531.531
Published: 2012
Journal Articles

Targeting the Hedgehog Signaling Pathway in Therapy-Resistant BCR-ABL1 Positive Leukemia with Ponatinib

Seiichiro Katagiri, M.D., Tetsuzo Tauchi, M.D., Seiichi Okabe, M.D., Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, DMSci, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 63.
https://doi.org/10.1182/blood.V118.21.63.63
Published: 2011